Bill Text: CT HB05295 | 2018 | General Assembly | Introduced

---

Bill Title: An Act Concerning The Certification Of Pharmaceutical Sales Representatives.

Spectrum: Committee Bill

Status: (Introduced - Dead) 2018-03-01 - Public Hearing 03/05 [HB05295 Detail]

Download: Connecticut-2018-HB05295-Introduced.html

---

General Assembly		Raised Bill No. 5295
February Session, 2018		LCO No. 1486
		*01486_______PH_*
Referred to Committee on PUBLIC HEALTH
Introduced by:
(PH)

AN ACT CONCERNING THE CERTIFICATION OF PHARMACEUTICAL SALES REPRESENTATIVES.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

Section 1. (NEW) (Effective October 1, 2018) (a) As used in this section, "pharmaceutical sales representative" means a person who markets or promotes pharmaceuticals to one or more health care providers.

(b) The Commissioner of Public Health shall adopt regulations, in accordance with chapter 54 of the general statutes, requiring that any person who is employed as a pharmaceutical sales representative in the state be certified in accordance with a certification program developed by The University of Connecticut School of Pharmacy or the University of Saint Joseph School of Pharmacy.

This act shall take effect as follows and shall amend the following sections:
Section 1	October 1, 2018	New section

Statement of Purpose:

To require the certification of pharmaceutical sales representatives.

[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]